Mantle cell lymphoma and its management: where are we now?

Mantle cell lymphoma is a relatively new recognized hematological malignant disease, comprising of 2.5–6% non-Hodgkin’s lymphomas. The complexity of its clinical presentations (nodular pattern, diffuse pattern, and blastoid variant), variety in disease progression, and treatment response, make this...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladha, Abdullah, Zhao, Jianzhi, Epner, Elliot M., Pu, Jeffrey J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354396/
https://www.ncbi.nlm.nih.gov/pubmed/30733891
http://dx.doi.org/10.1186/s40164-019-0126-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354396/
https://www.ncbi.nlm.nih.gov/pubmed/30733891
http://dx.doi.org/10.1186/s40164-019-0126-0

Ejemplares similares